Testing a new device for heart bypass surgery
Part of Heart & circulation clinical trials.
This trial tests a new device called Elana for heart bypass surgery. It may help people who need multiple bypass grafts, including one to the left front artery of the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and agree to be in the study.
- You need to have a planned heart bypass surgery with at least two grafts, including one on the left front artery.
- You must be willing to come back for checkups for 2 years.
- You cannot be pregnant or breastfeeding, and if you could become pregnant, you need to use very reliable birth control.
- You cannot have had heart surgery before, and you must not be a current smoker or have quit for less than a year.
- You must not have other serious heart, kidney, or bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
This trial compares two types of heart bypass surgery for people with blockages in three main heart arteries. It tests a hybrid approach that combines a small incision bypass with a stent, versus a standard off-pump bypass. This may mean less recovery time for some patients.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial is comparing two common heart procedures—bypass surgery (CABG) and stents (PCI)—to see which works better for women with blockages in multiple heart arteries. It aims to find the best treatment for women, who are often underrepresented in heart research.
Hear when a new Coronary Artery Bypass Grafting (CABG) Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.